Target type: biologicalprocess
The chemical reactions and pathways resulting in the formation of protoporphyrinogen IX. [GOC:go_curators]
Protoporphyrinogen IX biosynthesis is a crucial metabolic pathway responsible for the synthesis of heme, a vital prosthetic group found in hemoglobin, myoglobin, cytochromes, and other heme proteins. Heme plays a critical role in oxygen transport, electron transport, and cellular respiration. The biosynthesis of protoporphyrinogen IX involves a series of enzymatic reactions that convert the amino acid glycine and succinyl CoA to protoporphyrinogen IX.
The pathway begins with the condensation of glycine and succinyl CoA to form α-amino-β-ketoadipate. This reaction is catalyzed by the enzyme δ-aminolevulinate synthase (ALAS). α-amino-β-ketoadipate is then decarboxylated to δ-aminolevulinate (ALA) by the enzyme α-amino-β-ketoadipate decarboxylase. Two molecules of ALA condense to form porphobilinogen (PBG) in a reaction catalyzed by the enzyme porphobilinogen synthase (hydroxymethylbilane synthase). Four molecules of PBG then assemble into a linear tetrapyrrole known as protoporphyrinogen IX through a series of enzymatic steps.
The biosynthesis of protoporphyrinogen IX is tightly regulated to ensure adequate heme production while preventing the accumulation of toxic intermediates. The first committed step in the pathway, catalyzed by ALAS, is subject to feedback inhibition by heme. This regulation ensures that heme synthesis is only initiated when necessary. In addition, the enzyme ferrochelatase, which catalyzes the final step in heme synthesis, is also regulated by heme levels.
Defects in protoporphyrinogen IX biosynthesis can lead to a variety of human diseases known as porphyrias. These disorders result from the accumulation of porphyrin precursors in erythrocytes, body fluids, and tissues. Symptoms of porphyrias can vary depending on the specific enzyme deficiency and the amount of porphyrin precursors accumulated. Some common symptoms include photosensitivity, abdominal pain, neurological disorders, and skin lesions.
The protoporphyrinogen IX biosynthetic pathway is a complex and tightly regulated process that is essential for life. It is a fascinating example of how metabolic pathways are integrated into cellular function and how defects in these pathways can lead to human disease. '
"
Protein | Definition | Taxonomy |
---|---|---|
Delta-aminolevulinic acid dehydratase | A delta-aminolevulinic acid dehydratase that is encoded in the genome of Escherichia coli K-12. [OMA:P0ACB2, PRO:DNx] | Escherichia coli K-12 |
Protoporphyrinogen oxidase | A protoporphyrinogen oxidase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P50336] | Homo sapiens (human) |
Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial | An oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial that is encoded in the genome of human. [PRO:DNx, UniProtKB:P36551] | Homo sapiens (human) |
Delta-aminolevulinic acid dehydratase | A delta-aminolevulinic acid dehydratase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P13716] | Homo sapiens (human) |
Porphobilinogen deaminase | A porphobilinogen deaminase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P08397] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
coproporphyrinogen iii | coproporphyrinogen | Escherichia coli metabolite; mouse metabolite | |
succinic acid | succinic acid : An alpha,omega-dicarboxylic acid resulting from the formal oxidation of each of the terminal methyl groups of butane to the corresponding carboxy group. It is an intermediate metabolite in the citric acid cycle. Succinic Acid: A water-soluble, colorless crystal with an acid taste that is used as a chemical intermediate, in medicine, the manufacture of lacquers, and to make perfume esters. It is also used in foods as a sequestrant, buffer, and a neutralizing agent. (Hawley's Condensed Chemical Dictionary, 12th ed, p1099; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1851) | alpha,omega-dicarboxylic acid; C4-dicarboxylic acid | anti-ulcer drug; fundamental metabolite; micronutrient; nutraceutical; radiation protective agent |
3-nitropropionic acid | 3-nitropropanoic acid : A C-nitro compound that is propanoic acid in which one of the methyl hydrogens has been replaced by a nitro group. 3-nitropropionic acid: succinate dehydrogenase inactivator; biosynthesized by FABACEAE plants from ASPARAGINE | C-nitro compound | antimycobacterial drug; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor; mycotoxin; neurotoxin |
aceturic acid | aceturic acid: structure N-acetylglycine : An N-acylglycine where the acyl group is specified as acetyl. | N-acetyl-amino acid; N-acylglycine | human metabolite |
levulinic acid | 4-oxopentanoic acid : An oxopentanoic acid with the oxo group in the 4-position. levulinic acid: inhibits 5-aminolevulinic acid dehydratase; RN given refers to parent cpd; structure in Merck Index, 9th ed, #5316 | oxopentanoic acid; straight-chain saturated fatty acid | plant metabolite |
2,5-dimethylpyrrole | 2,5-dimethylpyrrole: structure given in first source | pyrroles | |
oxadiazon | oxadiazon: manufactured by the Societe Rhone-poulenc, France; structure | aromatic ether | |
acifluorfen | aromatic ether; benzoic acids; C-nitro compound; monocarboxylic acid; organochlorine compound; organofluorine compound | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide | |
monomethyl succinate | monomethyl succinate : A dicarboxylic acid monoester that is succinic acid in which one of the carboxy groups has been converted to its methyl ester. monomethyl succinate: RN given refers to parent cpd | dicarboxylic acid monoester; hemisuccinate | |
n-(2,4-dichloro-5-(4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1h-1,2,4-triazol-1-yl)phenyl)methanesulfonamide | N-(2,4-dichloro-5-(4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl)phenyl)methanesulfonamide: FP 846 is purified form of sulfentrazone; protoporphyrinogen oxidase inhibitor sulfentrazone : A member of the class of triazoles that is 5-oxo-1,2,4-triazole which is substituted at positions 1, 3, and 4 by 2,4-dichloro-5-[(methylsulfonyl)amino]phenyl, methyl, and difluoromethyl groups, respectively. A protoporphyrinogen oxidase inhibitor, it is used as a herbicide to control broad-leaved weeds in soya and tobacco crops. Not approved for use within the European Union. | dichlorobenzene; organofluorine compound; sulfonamide; triazoles | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
5-benzimidazolecarboxylic acid | 5-benzimidazolecarboxylic acid: structure in first source |